For long-term orthopaedic implants, the creation of a surface that is repulsive to bacteria while adhesive to tissue cells represents a promising strategy to control infection. To obtain such multifunctional surfaces, two possible approaches were explored to incorporate a model antibiotic, rifampicin (Rf), into the osteogenic polycaprolactone (PCL)/chitosan (CHS) biomimetic nanofibre meshes by (1) blending Rf into the electrospinning solutions and then electrospinning into nanofibres (i.e., Rf-incorporating fibres), or (2) depositing Rf-containing poly(D,L-lacticco-glycolic) acid (PLGA) micro-patterns onto the PCL/ chitosan nanofibre meshes via ink-jet printing (i.e., Rfeluting micro-pattern/fibre). Rapid release of Rf from both meshes was measured even though a relatively slower release rate was obtained from the Rf-eluting micro-pattern ones. Antibacterial assay with Staphylococcus epidermidis showed that both mesh surfaces could effectively kill bacteria and prevent biofilm formation. However, only Rf-eluting micro-pattern meshes favoured the attachment, spreading and metabolic activity of preosteoblasts in the cell culture study. Furthermore, the Rf-eluting micro-pattern meshes could better support the osteogenic differentiation of preosteoblasts by up-regulating the gene expression of bone markers (type I collagen and alkaline phosphatase). Clearly, compared to Rf-incorporating nanofibre meshes, Rf-eluting micro-patterns could effectively prevent biofilm formation without sacrificing the osteogenic properties of PCL/chitosan nanofibre surfaces. This finding provides an innovative avenue to design multifunctional surfaces for enhancing bone tissue formation while controlling infection.
Introduction
Infection control on abiotic surfaces remains a longstanding challenge, which becomes particularly important considering that infection is one of the leading causes of orthopaedic implant failure (Campoccia et al., 2006) . Continuous innovation has been made to modify material surfaces for preventing bacterial colonisation, e.g., by grafting polyethylene glycol or other hydrophilic molecules to minimise bacterial adhesion (Bearinger et al., 2003; Banerjee et al., 2011) , or incorporating antibiotics into implant materials or coating layers for controlled release to kill bacteria (Lucke, 2003; Alt et al., 2006; Radin and Ducheyne, 2007) . While their efficiency in infection control has been demonstrated, there is no obvious evidence to show that these approaches would promote tissue growth. Tissue-integration with implant surface is not required for those implants for the temporary fracture fixation Moriarty et al., 2009; Hayes et al., 2010; Moriarty et al., 2010; Hayes et al., 2012) ; however, it becomes highly crucial for long-term implants such as hip prostheses. It is recognised that the fate of long-term orthopaedic implants mainly depends on the surface race between successful osseointegration and unwanted biofilm formation (Gristina, 1987) and an ideal surface for such orthopaedic implants should be repulsive to bacteria while adhesive to bone tissue cells. Following this concept, efforts to modify the surface with differential functionality for preventing biofilm formation and promoting bone tissue formation will be of great benefit. Up to now, very limited progress has been made in designing such multifunctional surfaces. Seminal efforts were made to functionalise titanium substrates with covalently grafted chitosan, hyaluronic acid or their derivatives to suppress bacterial adhesion, while enhancing osseointegration with immobilised RGD peptides or growth factors (Shi et al., 2008; Shi et al., 2009; Hu et al., 2010) . With promising evidence in reducing bacterial adhesion and enhancing osteogenesis, the involvement of two chemical modification steps in this approach could potentially complicate its application. Thus, more costeffective approaches are preferred.
Recently, electrospun fibre meshes have received great attention as growth substrates for various cells and tissues, due to the simple electrospinning setup and the possibility of forming fibres from a variety of polymers, and more importantly, their morphological and dimensional similarity to native extracellular matrix (ECM). The flexibility to incorporate various biomolecules into electrospun nanofibre allows the configuration of specific www.ecmjournal.org
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Biomimetic nanofibres for infection control substrates for desired tissue formation. For example, blending type I collagen into polycaprolactone (PCL) fibres can significantly improve the adhesion and growth of fibroblasts for soft tissue regeneration (Venugopal et al., 2006; Yang et al., 2009b) . Our previous study has shown that PCL/chitosan composite fibres support the adhesion and proliferation of preosteoblasts and their osteogenic differentiation (Yang et al., 2009a) . In order to prevent infection, it is possible to include antifouling molecules or antimicrobial drugs into electrospun nanofibres (Kenawy et al., 2002; Katti et al., 2004; Kim et al., 2004) . With the application mainly focused on antimicrobial effects or preventing postsurgery-induced abdominal adhesions (Bölgen et al., 2007; Zong et al., 2004) , little attention was paid to their potential effects on tissue cells. It is known that nanofibres regulate cell adhesion by interacting with various cell membrane integrins to form focal adhesion plaques as a synergistic result of both fibre morphology and surface chemistry (Schindler et al., 2005; Yin et al., 2010) , which in turn regulate the cell phenotype . The incorporation of such molecules in electrospun nanofibres would alter the surface properties and consequently lead to a differential cellular response. In this regard, we propose a novel strategy to introduce the antimicrobial function to electrospun nanofibre meshes while maintaining the osseointegration capacity of nanofibres. In this strategy, drug-eluting bioresorbable micro-patterns are created on the nanofibre mesh surfaces to release antimicrobial drugs that prevent bacterial colony formation. The micro-patterns can be produced with recent advances in "demand-ondrop" printing and patterning of nanocomposite materials via evaporative assembly, along with the significant progress in inkjet printing onto three-dimensional (3D) object surfaces with multi-axis robotics (Hamade et al., 2005) . Thus, the aim of this study is to demonstrate the efficacy of electrospun PCL/chitosan nanofibre meshes with antibiotic-eluting micro-patterns in preventing infection while promoting osteogenesis. The hypothesis is that antibiotics incorporated into micro-patterns would not affect the behaviour of tissue cells on nanofibre surfaces and its release can effectively kill the bacteria.
In this study, rifampicin (Rf) was used as a model antibiotic for its potency in managing bone infection and its effectiveness against Staphylococci (O'Reilly et al., 1992; Zimmerli et al., 1998) . Rf is often recommended to be used in combination with other antibiotics (Zimmerli et al., 2004 ) to achieve optimal efficacy and minimise the bacterial resistance (Shasha et al., 1994) . However, our previous result showed that Rf alone was effective to kill planktonic S. epidermidis of NJ9709 strain (Lee et al., 2011) , which was used as the bacterium model in this study. To prove the hypothesis and achieve the multifunctionality of the multi-scale surfaces, a periodic array of poly(D,L-lactic-co-glycolic) acid (PLGA) circular patterns (~75 mm in diameter and ~150 mm apart between the centres of two adjacent micro-patterns) containing Rf were printed onto electrospun PCL/chitosan nanofibre meshes (Fig. 1) . The Rf-containing PCL/chitosan nanofibre meshes ( Fig. 1) were also included in the study for sideby-side comparison of the advantages of new multiscale surfaces. The capabilities of such Rf-incorporated surfaces in killing S. epidermidis bacteria and supporting osteogenesis of preosteoblasts were investigated. This finding would provide us with an innovative avenue to design multifunctional surfaces for both controlling infection and enhancing bone tissue formation, which can be used to improve the surface of permanent orthopaedic implants in the near term and prevent infection in tissueengineered grafts in the long run.
Materials and Methods
Materials 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) was obtained from Oakwood Products (West Columbia, SC, USA). Poly (ε-caprolactone) (PCL, molecular weight = 80,000) and chitosan (CHS, medium molecular weight) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dimethyl sulphoxide (DMSO, ≥ 99 %) from Sigma-Aldrich was used as a solvent for PLGA (5050DLG3E, Mw 25,000, 50 wt% PLA, Lakeshore Biomaterials, Birmingham, AL, USA) and rifampicin (Rf) (≥ 97 %, Sigma-Aldrich). Foetal bovine serum (FBS) was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All other reagents and solutions were obtained from Invitrogen/Life Technologies (Carlsbad, CA, USA) except as indicated. 
Electrospinning and characterisation
Various nanofibres were prepared using established electrospinning techniques as described elsewhere (Yang et al., 2009a 
Micro-pattern formation and characterisation
Rf containing PLGA circular patterns were directly printed on the 1:1 (v/v) PCL/chitosan nanofibre surface (abbreviated as EFRM) using a commercial inkjet printer (Dimatix Materials Printer, DMP2800, FUJIFILM Dimatix, Santa Clara, CA, USA) as described elsewhere (Gu et al., 2012) . The printer utilises micro-fabricated piezoelectric nozzles for on-demand and programmable generation of 10 pL droplets of jetting solutions with spatial resolution of ~50 µm. Briefly, the jetting solution was prepared by dissolving PLGA (6 wt%) and Rf (1 wt%) in DMSO at ~50 °C and stirring in the dark overnight. The prepared solution was transferred to the printer cartridge with a syringe and then ultrasonicated for 20 min. The firing voltage, nozzle temperature, substrate temperature, nozzle-substrate distance, droplet spacing, and interlayer delay for the printing were set at 30 V, 35 °C, 45 °C, 0.5 mm, 150 μm and 90 sec, respectively. 20 layers of Rf-containing micro-patterns were printed on EF. To characterise the morphology and size of circular micropatterns, the collected samples were sputter-coated with gold and examined with SEM. Randomly selected images (n = 5) were used to measure the micro-pattern size and inter-pattern distance.
Release kinetics of Rf
To determine the antibiotic release, the amount of Rf per sample (n = 6) was accurately measured as 44.3 ±4.3 μg for REF and 43.7 ±3.7 μg for EFRM (p > 0.05), respectively. Then the samples were incubated in 2 mL phosphate buffered saline solution (PBS, pH = 7.0) at 37 °C under shaking at 50 rpm. At designated time intervals, the supernatant was collected and immediately replenished with an equal amount (2 mL) of fresh PBS in an "infinite sink" release fashion. The average Rf concentration in the collected supernatant was determined by measuring the absorbance at 330 nm (Otto et al., 2008 ) using a Synergy TM HT multi-detection microplate reader (BioTek Instruments, Winooski, VT, USA). The UV absorbance of Rf was then converted to the concentration based on the obtained linear standard curve (Rf: 0-40 μg/mL, r 2 > 0.997). The measurement was performed at one-hour intervals for up to three days. The cumulative release of Rf at designated time was calculated. The percentage of total released Rf was calculated by dividing the cumulative amount of Rf in the supernatant by the total amount of Rf initially included in REF and EFRM.
Bacterial culture
Prior to testing, various substrates (EF, REF and EFRM, n = 6) collected on glass cover slips were UV sterilised for 30 min in 6-well plates. An inoculum of S. epidermidis biofilm strain, NJ9709, obtained from the surface of an infected intravenous catheter, was prepared as described previously (Kaplan et al., 2004) . The final inoculum was diluted in trypticase soy broth (TSB) medium at a final concentration of approximately 1×10 7 colony forming unit (CFU)/mL as counted by the Petroff-Hausser counting chamber (Electron Microscopy Sciences, Hatfield, PA, USA) before inoculation and confirmed by agar plating the next day. 2 mL bacterium-containing TSB medium was added to each well. After culturing for 5 hours, the supernatant from each culture was collected and planktonic bacteria in the supernatant were analysed by agar plating (n = 3). At the end of culture, half of the samples (n = 3) were stained with a live/dead fluorescent staining kit (SYTO9 green and propidium iodide: BacLight TM Bacterial Viability Kit, Invitrogen/Life Technologies) for 15 min and then examined with a Nikon Eclipse 80i fluorescent microscope (Nikon). The other half (n = 3) were stained with 0.75 wt% crystal violet for 5 min and then the stain was dissolved in 1 mL of 30 % acetic acid. 200 mL of the supernatant was transferred to a 96-well plate to measure the optical density (OD) using a Synergy HT multidetection microplate reader at 595 nm.
Osteoblastic cell culture
Mouse preosteoblasts (MC 3T3-E1) from bone calvaria were cultured in α-minimum essential medium (α-MEM) supplemented with 10 % FBS, 1 % penicillin/streptomycin. The culture was maintained at 37 °C with 5 % CO 2 until 70-80 % confluence prior to use.
Cell metabolic activity
The metabolic activity of MC 3T3-E1 on various substrates (REF, EFRM, and EF) was quantified by using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, which can be used to reliably measure cell metabolic activity in vitro for assessing cell growth (Sieuwerts et al., 1995) . Briefly, after UV-sterilisation and medium incubation, the substrates (n = 3) were seeded with MC 3T3-E1 cells at a density of 5 × 10 4 cells per sample for overnight. Complete culture media (α-MEM supplemented with 10 mM β-glycerophosphate, 10 -7 M dexamethasone
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and 80 mg/mL ascorbic acid) was used to continuously culture for 1, 3 and 7 days. The culture was rinsed with PBS and then incubated with α-MEM media containing 10 % MTT solution (5 mg/mL, Sigma-Aldrich) for 2 h at 37 °C. Then the unreacted MTT solution was discarded and the metabolically formed formazan was extracted with DMSO. 200 µL of the extract was transferred to a 96-well plate and the absorbance was measured with the Synergy TM HT multi-detection microplate reader at 570 nm.
Cell morphology
After culturing for one and three days, samples were fixed in 4 % formaldehyde and permeabilised with 0.5 % Triton X-100 in PBS. The cells were stained with TRITCconjugated-phalloidin (50 µg/mL from Sigma-Aldrich) for 40 min at room temperature and then the cell nuclei were stained with DAPI in Vectashield mounting medium (Vector Lab, Burlingame, CA, USA). Stained cells were examined with a Nikon 80i fluorescent microscope.
Gene expression
To compare the ability of various substrates (EF, REF and EFRM, n = 3) to induce the osteogenesis of preosteoblasts, reverse transcriptase polymerase chain reaction (RT-PCR) was performed on the cultured cells for marker gene expression. Total RNA was isolated using the Multisource Total RNA Miniprep Kit (Axygen Biosciences, Union City, CA, USA) and then reverse-transcribed into complementary DNA (cDNA) using the SuperScript First-Strand Synthesis System (Promega, Madison, WI, USA). The cDNA product was then amplified using recombinant Taq DNA polymerase (Promega). Expressions of type I collagen (COL-1; sense, 5′-TCTCCACTCTTCTAGTTCCT-3′; antisense, 5′-TTGGGTCATTTCCACATGC-3′, 269 bps), alkaline phosphatase (ALP; sense, 5'-GGGACTGGTACTCGGATAACGA-3'; antisense, 5'-CTGATATGCGATGTCCTTGCA-3', 7 1 b p s ) a n d o s t e o p o n t i n ( O P N ; s e n s e , 5′-ATGAGATTGGCAGTGATTTG-3′; antisense, 5 ′ -G T A G G G A C G AT T G G A G T G A A -3 ′ , 4 1 0 b p s ) w e r e e x a m i n e d . β -a c t i n ( s e n s e , 5'-AACCCTAAGGCCAACCGTG-3'; antisense, 5'-CAGGATTCCATACCCAAGAAG-3', 485 bps) served as the house-keeping gene control. All genes were amplified for 30 cycles in a thermocycler (Eppendorf Mastercycler gradient, Brinkmann, Westbury, NY, USA). Semi-quantitative analysis of gene expression was performed, and band intensity was normalised to that of b-actin.
Statistical analysis
Each experiment was repeated at least 3 times on different days and data were expressed as the mean ± standard deviation (SD). All the data were collected in triplicate for each group. 
Results

Fabrication and characterisation of biomimetic substrates
To prevent the colonisation of S. epidermidis, Rf, an active antibiotic was either directly incorporated into the PCL/ chitosan nanofibres while electrospinning (defined as REF in Fig. 1 ) or incorporated into PLGA micro-patterns that were deposited onto the PCL/chitosan nanofibre meshes (defined as EFRM in Fig. 1 ). Fig. 2b and c insets) . Although the inclusion of Rf into PCL/chitosan electrospun nanofibres did not significantly change the average fibre diameter (Table 1) and fibre surface morphology ( Fig. 2d and 2e insets) , it caused non-uniform electrospun nanofibres as evidenced by bead formation (Fig. 2e) (Fig. 3) . The deposition of Rf-containing micro-patterns, composed of arrays of dried Rf/PLGA droplets with ~75 µm in diameter ( Fig. 2c and  inset) , onto PCL/chitosan nanofibre meshes did not affect the nanofibre morphology, while a tight bonding formed between the micro-patterns and the nanofibres (Fig. 2f) .
Controlled release of Rf
The release of Rf from either REF or EFRM was performed in PBS (pH 7.0) at 37 °C for up to three days with Rf-free EF as controls (n = 3). With a similar release pattern, i.e., an initial burst release and cumulative release over a period of three days, a faster release rate was measured in REF compared to EFRM (Fig. 4) . After one-hour incubation, about 71.9 % of the initially loaded Rf was released from REF, reaching 14.8 µg/mL in the supernatant. In comparison, about 41.7 % of the initially loaded Rf was released from EFRM for a concentration of 8.6 µg/mL in the supernatant. After 24 h, all Rf was released from REF, while 3.3 % Rf still remained in the PLGA micro-patterns of EFRM and was completely released in another 24 h. In both groups, the cumulatively released Rf drastically exceeded the minimal bactericidal concentration (MBC, 0.5 µg/mL) (Monzon et al., 2001) , sufficient to kill those S. epidermidis coming to the implant surface.
Bacterial culture
After 5 h bacterial culture, crystal violet staining showed that EF gave the most intense staining and EFRM the lowest one, and there was no significant difference between EFRM and REF (Fig. 5a) . Quantification of the staining by measuring the OD value of the extracts of crystal violet staining (n = 3) confirmed this observation, showing that the EF group stained approximately 6 times more than the REF group and 9 times more than the EFRM group (Fig. 5b) . Close examination of the staining revealed the presence of only individual S. epidermidis cells in both REF and EFRM groups (white arrows in Fig. 5e and f insets) in contrast to large purple clumps in the EF group (asterisk of Fig. 5d inset) . The fluorescent live/dead 
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staining showed that only dead bacteria were detected in either REF or EFRM (red dots in Fig. 5h and i insets) , while the large clump in EF controls contained a great quantity of live S. epidermidis as indicated by the intense green fluorescence in Fig. 5g . It is necessary to point out that the large and irregular fluorescent dots in Fig. 5h were artefacts from the beads formed during the electrospinning. The result of the agar-plating assay showed that no planktonic S. epidermidis was found in the supernatants of both REF and EFRM, while approximately 1.0 × 10 9 CFU/mL S. epidermidis was detected from the Rf-free EF controls (Fig. 5c ).
Preosteoblast culture
The fluorescent staining of the cellular cytoskeleton filament actin (F-actin) showed that distinct cell morphology was noticed among various substrates as early as day 1. On both EF and EFRM, preosteoblasts began to adhere and spread in a polygonal morphology (Fig. 6a and c) , while a constrained yet slim morphology (Fig. 6b) was consistently observed on the REF substrates even after 3-day culture (Fig. 6e) . No noticeable difference could be identified between EF and EFRM. The MTT results (n = 3) showed that a significantly lower cell metabolic activity was measured in REF group at day 1 and 3, in comparison to both EF and EFRM groups (p < 0.01), and the difference became less obvious by 7 days after media change. Consistent with the fluorescent staining result, cell metabolic activity between EF and EFRM was comparable at all the investigated time points (Fig. 7) .
The RT-PCR results (n = 3) showed that no significant difference was found in OPN expression among all three 
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Biomimetic nanofibres for infection control groups (data not shown), however, the expression of both type I collagen (COL-1) and alkaline phosphatise (ALP) was noticeably lower on the REF substrates (Fig. 8a) and semi-quantification of the expression intensity confirmed this observation (Fig. 8b) . No significant difference between EF and EFRM was measured in both ALP and COL-1 gene expression (Fig. 8) .
Discussion
The failure of long-term orthopaedic implants has mainly resulted from bacterial infection and implant loosening due to poor adhesion to host bone tissue ( Van de Belt et al., 2001; Campoccia et al., 2006) , so the intrinsic competition between infectious bacteria and tissue-forming cells for implant surface determines the benefits to design a cell-adhesive, bacteria-repulsive surface. Multistep efforts were made to modify the titanium surface with covalently grafted chitosan, hyaluronic acid or their derivatives to suppress bacterial adhesion, and immobilise RGD peptide or growth factors to enhance osseointegration (Shi et al., 2008; Shi et al., 2009; Hu et al., 2010) . However, these approaches involved not only two main chemical modification steps, but also several preparing and cleaning steps, which could potentially complicate its application by requiring a longer time and more chemicals to modify the titanium surface. In this regard, the present study was aimed to develop a simple and cost-effective strategy for modifying the implant surface with a similar multi-functionality and meanwhile applicability to a wider range of long-term orthopaedic implant substrates. Compared to previous efforts, the new approach only needed two steps, i.e., electrospinning and micro-pattern printing, which could be completed in several hours with a few economical chemicals. Thus, this approach can be readily translated into "clinically appropriate large scale production techniques" (Ozkan et al., 2009 ) with reproducibility and cost-effectiveness. The advantages of electrospun PCL/chitosan nanofibres (EF) in promoting bone cell adhesion and differentiation have been highlighted as a result of their morphological similarity to native ECM fibrils and the presence of chitosan (Yang et al., 2009a) . However, high bacterial adhesion to such nanofibrous meshes was also observed in the present study (Fig. 5a ) and as reported previously . To address this challenge, the incorporation of antibiotics into nanofibres seems to be a plausible solution (Zeng et al., 2003; Liang et al., 2007; Sill and von Recum, 2008) . By electrospinning the blended solutions containing a model antibiotic, Rf, Rf-containing PCL/chitosan nanofibres with a similar diameter to pure PCL/chitosan nanofibres ( Fig. 2d and 2e , Table 1) were produced. Theoretically, the lipophilic nature of Rf (Zeng et al., 2003) would allow a complete dissolution of Rf in the PCL/chitosan solution to form a homogeneous blended solution and therefore produce the nanofibres with evenly distributed Rf. Indeed, most of the Rf distributed www.ecmjournal.org
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Biomimetic nanofibres for infection control uniformly across the PCL/chitosan nanofibre surface and it was confirmed by using a fluorescent substitute with comparable molecular weight, rhodamine 610 (Exciton, Dayton, OH, USA) (data not shown). However, a few large beads in dark red were also observed among the nanofibres (Fig. 2b inset and 2e ). This may be ascribed to the possible binding of anionic RF with cationic chitosan to form complexes (Cao and Sun, 2009) , which reduced the solution viscosity from 5.3×10 -2 (PCL/chitosan) to 4.9×10 -2 kg m -1 s -1 (PCL/chitosan/Rf) and affected the electrospinning process (Pham et al., 2006) . The high surface area/volume ratio of nanofibres allowed a rapid release of Rf (Fig. 4) , consistent with our previous observation with BSA release . Additionally, during electrospinning the fast solvent evaporation and the high ionic strength of Rf in the solution might lead to the distribution of Rf mainly on the surface of PCL/chitosan fibres (Fig. 2b) , which consequently causes an initial burst release of Rf (Zeng et al. 2003; Kim et al., 2004; He et al., 2009) .
Rapid release of Rf from PCL/chitosan fibres results in a high Rf concentration in the culture sufficient to kill S. epidermidis and prevent biofilm formation. Indeed, only individual S. epidermidis bacteria were observed in the Rf-containing nanofibres (Fig. 5e ) and a majority of them were stained dead (Fig. 5h) . It is necessary to mention that Rf may not be the best choice, however, it demonstrates its effectiveness as a model antibiotic to kill planktonic S. epidermidis of NJ9709 strain in this study, i.e., where it was incorporated into PCL/chitosan nanofibres (REF) or PLGA micro-patterns (EFRM), and it can be easily replaced with a better one or a cocktail due to the flexibility of our approach. Our previous study has shown a negligible toxicity of Rf to osteoblasts even up to 60 µg/mL (Lee et al., 2011) , which is about two times higher than the maximum Rf concentration (i.e., 22.8 µg/mL) released from REF or EFRM in this study. However, the homogeneous distribution of RF across PCL/chitosan nanofibres could change the surface properties of nanofibres (Fig. 3) . Clearly, variation in surface properties would modulate the interactions between electrospun nanofibres and cell membrane integrin receptors (Huang et al., 2008; Tambralli et al., 2009; Kwei et al., 2010) , which are closely associated with intracellular signalling, and therefore affects the cell metabolic activity and differentiation (Giancotti, 1999; Schwartz and Assoian, 2001) . Indeed, the attachment and spreading of preosteoblasts on REF were noticeably different from those on EF (Fig. 6 ). Significantly lower cell metabolic activity was measured on REF for up to 3 days compared to EF meshes. Since Rf was completely released from the nanofibres after two days (Fig. 4) , no Rf was left in the fibres after medium change on day 3. As a result, the difference in cell metabolic activity on day 7 became less pronounced among all three groups (Fig. 7) , further suggesting the unfavourable effect of Rf presented in the PCL/chitosan nanofibres. Similar results were also consistently observed with other tissue cells such as fibroblasts (data not shown). Moreover, it was confirmed that the presence of Rf in the PCL/chitosan nanofibres decreased the expression of osteogenic markers (Fig. 8) .
To minimise the detrimental influence of Rf to the surface properties of PCL/chitosan nanofibres, it is possible to encapsulate Rf in the core to form core-shell nanofibres via coaxial electrospinning (Sun et al., 2003; Jiang et al., 2005; Zhang et al., 2007) . However, prolonged processing and narrow drug loading capacity could be a challenge in adopting this technique, apart from the need of special setups (Maretschek et al., 2008) . Deposition of Rf-eluting PLGA micro-patterns on PCL/chitosan nanofibre meshes allows the incorporation of Rf onto the nanofibre substrate without changing the surface properties (Fig. 2) . Different from the uniform distribution of Rf in REF fibres, Rf in PLGA micro-patterns disperses as discrete particles of ~10-100 nm (Gu et al., 2012) as a result of the re-crystallisation of Rf with slow evaporation of DMSO during ink-jet patterning. The distinct appearance of Rf in REF and PLGA micro-patterns of EFRM probably contributes partially to the differential release profile of Rf as shown in Fig. 4 . In addition, the slower Rf release from EFRM may also come from the fact that Rf particles were effectively embedded in PLGA micro-patterns and its release would greatly depend on the degradation kinetics of the PLGA matrix (Polakovic et al., 1999; Commandeur et al., 2006; Gu et al., 2012) . In this regard, it is possible to decelerate the Rf release rate by utilising less hydrophilic PLGA or increasing the molecular weight of PLGA (Murakami et al., 2000) . Although a slower Rf release rate was measured from the EFRM substrates (about 58.0 % of REF in 1 h), sufficient Rf was released within the first hour (much higher than MBC of 0.5 µg/mL) to eradicate S. epidermidis and stunt biofilm formation. Earlier studies have demonstrated the necessity of rapidly releasing antibiotics within a few hours after surgery to efficiently eliminate the bacteria before they begin to proliferate (Bölgen et al., 2007; He et al., 2009; Yoo et al., 2009) . The culture of preosteoblasts on EFRM substrates did not adversely affect the cellular response, and instead followed a similar pattern to those on the EF controls in terms of cell spreading, proliferation and differentiation (Fig. 6-8 ). The possible explanations to this are (1) the 75 mm Rf-containing PLGA micropattern arrays deposited on the nanofibre meshes only take about 20 % of the total surface area, and (2) the 150 mm inter-micro-pattern distance is large enough for the preosteoblasts to attach, spread and proliferate onto the intact PCL/chitosan nanofibre surfaces. Considering that only one micro-pattern configuration was used in this study, our further efforts will focus on addressing whether reduced micro-pattern separation distances can affect the behaviour of preosteoblasts.
In this study, the effort to integrate biomimetic nanofibres with antibiotic-eluting micro-patterns for possible modification of orthopaedic implant surfaces was the first attempt to minimise infection and promote bone tissue formation. With the successful demonstration of the dual function, our continuous efforts will focus on the integration of such fibre meshes to implant surface. Interestingly, our initial measurement has shown a good bonding force between electrospun nanofibre meshes and smooth titanium alloy (TiAl 6 V 4 ) substrates (the roughness is ~0.05 mm) (data not shown), close to the strength of human bone (~18 MPa) (Kar et al., 2006) , suggesting its
Biomimetic nanofibres for infection control good resistance to mechanical disruption and potential use for implant surface. Furthermore, its application can also be extended to other possibilities, e.g., to modify other types of long-term implants by choosing appropriate nanofibres and drugs or to be used as wound dressing and surgical meshes.
Conclusions
For those long-term orthopaedic implants, the design of a multifunctional surface to minimise infection while supporting tissue formation represents a promising paradigm. In recognition of the stimulatory effect of PCL/ chitosan biomimetic nanofibres on tissue formation, the incorporation of antibiotics (e.g., Rf) to nanofibre meshes for infection control may achieve the desired multifunctionality. In this study, deposition of Rf-containing PLGA micro-patterns (~75 mm in diameter and ~150 mm apart) onto PCL/chitosan electrospun nanofibres yield a multifunctional substrate, which can effectively kill S. epidermidis and prevent biofilm formation without sacrificing the osteogenic properties of PCL/chitosan nanofibres. Taken together, the present study provides further evidence to the emerging efforts in designing multifunctional surfaces for enhancing bone tissue formation while controlling infection.
